BRITTANY LAMBOY: Open Payments
NPI 1023619970 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 32 payments from 13 companies in 2025. Trend: 2023 $603 · 2024 $416 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Incyte Corporation | 3 | $58 |
| Organon LLC | 6 | $58 |
| Lilly USA, LLC | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $52 |
| ABBVIE INC. | 3 | $46 |
| GENZYME CORPORATION | 2 | $40 |
| Amgen Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $31 |
| Botanix SB Inc | 1 | $19 |
Products named: OPZELURA, COSENTYX, TALTZ, DUPIXENT, OTEZLA, Winlevi, HADLIMA, SKYRIZI.
Industry payments across NJ — which companies pay providers there.
